Switch theme
Sign up to access all valuation multiples
Vitrafy Life Sciences Ltd developed a range of proprietary smart cryopreservation hardware devices and Lifechain, an integrated, cloud-based software platform, to provide a complete, vertically integrated cryopreservation solution, to retain the quality of cryopreserved biomaterials.
2017
n/a
LTM Revenue $0.4M
LTM EBITDA -$11.0M
$40.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Vitrafy has a last 12-month revenue (LTM) of $0.4M and a last 12-month EBITDA of -$11.0M.
In the most recent fiscal year, Vitrafy achieved revenue of $24K and an EBITDA of $5K.
Vitrafy expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Vitrafy valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $0.4M | XXX | $24K | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | $24K | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | 100% | XXX | XXX | XXX |
| EBITDA | -$11.0M | XXX | $5K | XXX | XXX | XXX |
| EBITDA Margin | -2648% | XXX | 19% | XXX | XXX | XXX |
| EBIT | -$11.0M | XXX | -$7.0M | XXX | XXX | XXX |
| EBIT Margin | -2652% | XXX | -28835% | XXX | XXX | XXX |
| Net Profit | -$22.9M | XXX | -$6.8M | XXX | XXX | XXX |
| Net Margin | -5499% | XXX | -28176% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 16, 2025, Vitrafy's stock price is AUD 1 (or $1).
Vitrafy has current market cap of AUD 95.5M (or $62.5M), and EV of AUD 61.4M (or $40.2M).
See Vitrafy trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $40.2M | $62.5M | XXX | XXX | XXX | XXX | $-0.17 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 16, 2025, Vitrafy has market cap of $62.5M and EV of $40.2M.
Vitrafy's trades at 896.9x EV/Revenue multiple, and -7.2x EV/EBITDA.
Equity research analysts estimate Vitrafy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Vitrafy has a P/E ratio of -2.7x.
See valuation multiples for Vitrafy and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $62.5M | XXX | $62.5M | XXX | XXX | XXX |
| EV (current) | $40.2M | XXX | $40.2M | XXX | XXX | XXX |
| EV/Revenue | 96.8x | XXX | 896.9x | XXX | XXX | XXX |
| EV/EBITDA | -3.7x | XXX | -7.2x | XXX | XXX | XXX |
| EV/EBIT | -3.6x | XXX | -4.4x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | -2.7x | XXX | -4.1x | XXX | XXX | XXX |
| EV/FCF | -4.5x | XXX | -6.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialVitrafy's last 12 month revenue growth is 2008%
Vitrafy's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Vitrafy's rule of 40 is -2069% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Vitrafy's rule of X is 2373% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Vitrafy and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2008% | XXX | 1797% | XXX | XXX | XXX |
| EBITDA Margin | -2648% | XXX | -12404% | XXX | XXX | XXX |
| EBITDA Growth | -27% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -2069% | XXX | -10395% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 2373% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 11481% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 28935% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Vitrafy acquired XXX companies to date.
Last acquisition by Vitrafy was XXXXXXXX, XXXXX XXXXX XXXXXX . Vitrafy acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Vitrafy founded? | Vitrafy was founded in 2017. |
| Where is Vitrafy headquartered? | Vitrafy is headquartered in Australia. |
| Is Vitrafy publicy listed? | Yes, Vitrafy is a public company listed on ASX. |
| What is the stock symbol of Vitrafy? | Vitrafy trades under VFY ticker. |
| When did Vitrafy go public? | Vitrafy went public in 2024. |
| Who are competitors of Vitrafy? | Similar companies to Vitrafy include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Vitrafy? | Vitrafy's current market cap is $62.5M |
| What is the current revenue of Vitrafy? | Vitrafy's last 12 months revenue is $0.4M. |
| What is the current revenue growth of Vitrafy? | Vitrafy revenue growth (NTM/LTM) is 2008%. |
| What is the current EV/Revenue multiple of Vitrafy? | Current revenue multiple of Vitrafy is 96.8x. |
| Is Vitrafy profitable? | Yes, Vitrafy is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Vitrafy? | Vitrafy's last 12 months EBITDA is -$11.0M. |
| What is Vitrafy's EBITDA margin? | Vitrafy's last 12 months EBITDA margin is -2648%. |
| What is the current EV/EBITDA multiple of Vitrafy? | Current EBITDA multiple of Vitrafy is -3.7x. |
| What is the current FCF of Vitrafy? | Vitrafy's last 12 months FCF is -$8.9M. |
| What is Vitrafy's FCF margin? | Vitrafy's last 12 months FCF margin is -2136%. |
| What is the current EV/FCF multiple of Vitrafy? | Current FCF multiple of Vitrafy is -4.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
